REUTERS: AstraZeneca Plc will pay up to US$6.9 billion to work with Daiichi Sankyo Co Ltd on a hotly-tipped experimental treatment for breast cancer, in a direct challenge to the world's biggest cancer drug maker Roche.
Daiichi's drug, also known as DS-8201, targets the HER2 protein, a major trigger of uncontrolled cell growth in about 20 percent of breast cancers, where Roche has been a pioneer with its aging US$7 billion-a-year best-seller Herceptin. The deal is a big bet on Japanese research by AstraZeneca Chief Executive Pascal Soriot, who is seeking to replicate recent success in fast growing cancer drugs Tagrisso, Lynparza and Imfinzi.
The two drugmakers have a long-standing relationship which includes a 2015 agreement to jointly commercialize constipation drug Movantik in the United States.
Source: Healthcare Press (healthcarepress.net)
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
AstraZeneca could pay Daiichi Sankyo up to US$6.9 billion in cancer drug dealAstraZeneca Plc and Japan's Daiichi Sankyo Co Ltd have signed a potential multibillion-dollar collaboration to develop and sell Daiichi's cancer ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Daiichi Sankyo, AstraZeneca sign US$6.9 billion cancer drug dealAstraZeneca Plc and Japan's Daiichi Sankyo Co Ltd have signed a potential multibillion-dollar collaboration to develop and sell Daiichi's cancer ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
US jury says Bayer must pay US$81 million to man in Roundup cancer trialA U.S. jury on Wednesday awarded US$80.9 million to a man who claimed his use of Bayer AG's glyphosate-based weed killer Roundup caused his ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
US jury says Bayer must pay US$81m to man in Roundup cancer trialA U.S. jury on Wednesday awarded US$80.9 million to a man who claimed his use of Bayer AG's glyphosate-based weed killer Roundup caused his ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Uber could announce US$3 billion deal with Careem early this week: sourcesUber Technologies Inc is set to offer over US$3 billion to buy Dubai-based rival Careem Networks FZ, two sources familiar with the deal told Reuters.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Business chiefs deny US$5 billion fraud over HP-Autonomy dealLONDON: Bosses at a UK software firm, Autonomy, have denied committing fraud to inflate its value before selling the group to US tech giant ... + you've to rewire their shit all the time but you always forget when the computer is off so you're stuck with a crappy unit.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
EU approves AstraZeneca's drug for adjunct use in Type-1 diabetesREUTERS: British drugmaker AstraZeneca Plc said on Monday the European Commission approved its diabetes drug Forxiga for use as an oral supplement ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Uber buys rival Careem in $3.1 billion deal to dominate ride-hailing in Middle EastSAN FRANCISCO/DUBAI (Reuters) - Global ride-hailing firm Uber Technologies Inc will spend $3.1 billion to acquire Middle East rival Careem, buying dominance in a competitive region ahead of a hotly anticipated initial public offering. Uber said late on Monday night it would pay $1.4 billion in cash For the rich and elite Wrong link, sis.
Source: YahooSG - 🏆 3. / 71 Read more »
US experts: Too soon to pull breast implants tied to cancerGovernment medical advisers said Monday it's too soon to ban a type of breast implant that has recently been linked to a rare form of cancer, saying more information is needed to understand the problem. The Food and Drug Administration panel didn't recommend any immediate restrictions on breast
Source: YahooSG - 🏆 3. / 71 Read more »
Bayer shares sag after US jury verdict in Roundup cancer trialShares in Bayer hit an almost 7-year low on Thursday after a U.S. jury awarded US$80 million to a man claiming use of the group's weed killer ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »